Technology News and Research

RSS

Synpromics, Cell Therapy Catapult to create stable producer cell lines for large-scale manufacture of viral vectors

Synpromics Ltd, a leading synthetic biology company, and The Cell Therapy Catapult, the UK organisation accelerating the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announce the launch of a collaboration to remove a major barrier to the development of the cell and gene therapy industry by reducing the cost and increasing the scale and efficiency of viral vector manufacturing.

12 Jan 2016

New approach to package dual or more mixtures into a single capsule may boost drug efficiency

Researchers have developed a speedy, controllable way to get two or more ingredients into the same tiny capsule and only have them mix when triggered by a signal like vibrations or heat.

12 Jan 2016

Researchers use quick screening method to identify, test promising anti-Ebola drugs

A quick screening method has been used for the first time in a standard open laboratory to identify and test promising anti-Ebola drugs. This approach increases the possibility of finding new therapies faster.

12 Jan 2016

Strathspey Crown Holdings announces acquisition of Novus Via assets

Strathspey Crown Holdings LLC announced today the acquisition of the portfolio companies of Novus Via LP, a Nevada-based venture capital investment firm focused on end-stage development and commercialization of advanced electromagnetic and electrochemical technologies spanning healthcare, clean energy and coherent acoustics. The terms of the transaction were not disclosed.

11 Jan 2016

Sage Analytics establishes distribution network in South America

Sage Analytics, the developers of portable, laboratory-quality cannabis potency measurement systems, announced it established a distribution network in South America, anchored by Senses Biotech in Uruguay.

11 Jan 2016

AiCure closes $12.25 million in Series A fundraising round

AiCure, an artificial intelligence company connecting the world's patients to better treatments and improved health, has closed a Series A fundraising round with $12.25 million. The consortium is led by New Leaf Venture Partners, with additional participation from Pritzker Group Venture Capital, Tribeca Venture Partners, and Biomatics Capital, established by Boris Nikolic, former Chief Advisor for Science and Technology to Bill Gates.

11 Jan 2016

Bio2 Technologies receives 510(k) clearance from FDA for Fusion Implant system

Bio2 Technologies, Inc. announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Fusion Implant system for interphalangeal fusion, fracture repair and osteotomies of the toes, fingers and other small bones in the presence of appropriate immobilization.

11 Jan 2016

NIST chemist develops portable kit for recovering traces of chemical evidence

A chemist at the National Institute of Standards and Technology has developed a portable version of his method for recovering trace chemicals such as environmental pollutants and forensic evidence including secret graves and arson fire debris.

11 Jan 2016

Blocking brain inflammation could protect against memory, behaviour changes

A University of Southampton-led study has found that blocking a receptor in the brain responsible for regulating immune cells could protect against the memory and behaviour changes seen in the progression of Alzheimer's disease.

11 Jan 2016

F-star signs agreement with AbbVie to discover, develop bispecific antibodies in immuno-oncology

F-star today announced that it has entered into a collaboration and license agreement with AbbVie to research and develop bispecific antibodies in immuno-oncology. Financial terms were not disclosed.

11 Jan 2016

European clinicians to discuss broadcasts of latest research presented at 2016 Genitourinary Cancers Symposium

Today, Janssen-Cilag International NV announced that for the first time, European clinicians in six countries will meet to view and discuss broadcasts of the latest scientific research presented at the 2016 Genitourinary Cancers Symposium, co-sponsored by ASCO®.

11 Jan 2016

UTA researchers map out chemical mechanism of key enzyme found in autism, Alzheimer's and Down syndrome

Biochemists at The University of Texas at Arlington are mapping the catalytic processes of sulfur-oxidizing enzymes to improve understanding of the chemical imbalances found in patients with autism, Alzheimer's disease and Down syndrome.

11 Jan 2016

Wyss Institute scientists develop better assay for testing hemostasis

Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University have devised a better assay for testing blood's clotting tendency, also known as hemostasis, which could one day prove lifesaving in a variety of clinical situations in which a patient's health is jeopardized by abnormal blood coagulation and platelet function.

11 Jan 2016

Patient recommendations for rheumatoid arthritis treatment: an interview with Dr Nowell

The study, “When patients write the guidelines: Patient panel recommendations for the treatment of RA,” published in Arthritis Research & Care, demonstrated the feasibility of developing CPG recommendations based on a voting panel composed entirely of patients.

8 Jan 2016

New project aims to develop CAR-T cell immuno-oncology cellular therapy for solid tumours

The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, the University of Birmingham and Cancer Research Technology, the commercialisation arm of Cancer Research UK, announces today the launch of a collaboration to develop a new immuno-oncology cellular therapy based on gene modifying T cells to target solid tumours.

8 Jan 2016

Anthony Nolan introduces new tissue typing method that could revolutionise stem cell transplantation

Anthony Nolan has today launched a new tissue typing method that could significantly improve stem cell transplant outcomes.

8 Jan 2016

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

New Haven Pharmaceuticals, Inc. today announced the availability by prescription of DURLAZA, the first and only 24-hour, extended-release aspirin capsules (162.5mg) approved by the U.S. Food and Drug Administration (FDA) for the secondary prevention of stroke and acute cardiac events, including myocardial infarction (heart attack) in high-risk cardiovascular patients.

7 Jan 2016

ImpediMed introduces L-Dex system for clinical assessment of lymphedema in U.S.

ImpediMed Limited, a global provider of medical technology to measure, monitor and manage fluid status in patients, has announced the U.S. commercial launch of its L-Dex system to aid in the clinical assessment of lymphedema.

7 Jan 2016

Failure to accurately assess optic nerve drives IIH overdiagnosis

Researchers put overdiagnosis of idiopathic intracranial hypertension (IIH) down to inaccurate ophthalmoscopic examination in headache patients and wrongly suspecting the condition in young obese women with headaches.

7 Jan 2016

New handheld blood test to detect and evaluate concussions to be developed by Philips and Banyan Biomarkers

Royal Philips and Banyan Biomarkers, Inc. today announced that they have entered into a multi-year joint development agreement to develop and commercialize a new handheld blood test to detect and evaluate mild traumatic brain injury (TBI) - also known as concussion - at the point of care.

From Philips Healthcare 7 Jan 2016

Technology News and Research

Synpromics, Cell Therapy Catapult to create stable producer cell lines for large-scale manufacture of viral vectors

New approach to package dual or more mixtures into a single capsule may boost drug efficiency

Researchers use quick screening method to identify, test promising anti-Ebola drugs

Strathspey Crown Holdings announces acquisition of Novus Via assets

Sage Analytics establishes distribution network in South America

AiCure closes $12.25 million in Series A fundraising round

Bio2 Technologies receives 510(k) clearance from FDA for Fusion Implant system

NIST chemist develops portable kit for recovering traces of chemical evidence

Blocking brain inflammation could protect against memory, behaviour changes

F-star signs agreement with AbbVie to discover, develop bispecific antibodies in immuno-oncology

European clinicians to discuss broadcasts of latest research presented at 2016 Genitourinary Cancers Symposium

UTA researchers map out chemical mechanism of key enzyme found in autism, Alzheimer's and Down syndrome

Wyss Institute scientists develop better assay for testing hemostasis

Patient recommendations for rheumatoid arthritis treatment: an interview with Dr Nowell

New project aims to develop CAR-T cell immuno-oncology cellular therapy for solid tumours

Anthony Nolan introduces new tissue typing method that could revolutionise stem cell transplantation

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

ImpediMed introduces L-Dex system for clinical assessment of lymphedema in U.S.

Failure to accurately assess optic nerve drives IIH overdiagnosis

New handheld blood test to detect and evaluate concussions to be developed by Philips and Banyan Biomarkers

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News